Pharmaceutical products

Tender description

Framework Agreement for NHS Generic Pharmaceuticals. Offer reference number CM/PHG/17/5542 Period of Framework Agreement: dates detailed below with options to extend up to a maximum period of 48 months. Potential periods of call call-offs under the Framework Agreement: 100 % Products CM/PHG/17/5542/01 — All 3 regions (CESW; LSNE and NWLN) — 1.3.2019 until 28.2.2021 (24 months). 33 % Hospital Only Products CM/PHG/17/5542/02 — All 3 regions (CESW; LSNE and NWLN) — 1.3.2019 until 31.7.2019 (5 months). NHS National Generic Pharmaceuticals — 100 % Products Offer reference number: CM/PHG/17/5542/01 Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 48 months. Potential period of call-offs under the Framework Agreement: 100 % Products all regions 1.3.2019 to 28.2.2021 (24 months). NHS National Generic Pharmaceuticals - 33 % Hospital Only Products CESW Offer reference number: CM/PHG/17/5542/02 Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 10 months. Potential period of call-offs under the Framework Agreement: 33 % Hospital Only Products CESW 1.3.2019 to 31.7.2019 (5 months). NHS National Generic Pharmaceuticals — 33 % Hospital Only Products LSNE Offer reference number: CM/PHG/17/5542/02 Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 10 months. Potential period of call-offs under the Framework Agreement: 33 % Hospital Only Products LSNE 1.3.2019 to 31.7.2019 (5 months). NHS National Generic Pharmaceuticals — 33 % Hospital Only Products NWLN Offer reference number: CM/PHG/17/5542/02 Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 10 months. Potential periods of call-offs under the Framework Agreement: 33 % Hospital Only Products NWLN 1.3.2019 to 31.7.2019 (5 months).